COMPARATIVE-STUDIES OF IN-VITRO AND IN-VIVO FUNCTION OF 3 DIFFERENT SHAPED BIOARTIFICIAL PANCREASES MADE OF AGAROSE HYDROGEL

被引:47
作者
YANG, H
IWATA, H
SHIMIZU, H
TAKAGI, T
TSUJI, T
ITO, F
机构
[1] NATL CARDIOVASC CTR,RES INST,DEPT SURG RES,SUITA,OSAKA 565,JAPAN
[2] SETSUNAN UNIV,FAC PHARMACEUT SCI,DEPT BIOCHEM,HIRAKATA,OSAKA 57391,JAPAN
关键词
HYDROGELS; ARTIFICIAL PANCREAS; ENCAPSULATION;
D O I
10.1016/0142-9612(94)90259-3
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Various kinds of bioartificial pancreas (BAP) have been developed in the past. There have been many disputes about the advantages and disadvantages of each BAP. However, little attention has been paid to the shape of the devices. In this study, three different shaped BAPs were made of the same material, agarose hydrogel. These are microbead-, rod- and disc-shaped BAPs, which are comparable to microcapsules, hollow fibre diffusion chambers and disc-shaped diffusion chambers, respectively, in shape. Their performances were studied by in vitro culture, mathematical simulations and in vivo implantation into diabetic animals. The islets in the BAPs could survive and release insulin for more than 100 d regardless of the BAP shape during in vitro culture. Numerical analyses showed that insulin release kinetics depended greatly on the thickness of the gel membrane but not on the shape of the agarose hydrogel. The microbead BAP normalized blood glucose levels of all five recipients for more than 100 d. Three of eight recipients of the rod BAP and only one of six recipients of the disc BAP demonstrated long normoglycaemia. These results suggest that the shape of the BAPs determines the in vivo functioning period of the BAPs and that the microbead is the most suitable shape for the BAP.
引用
收藏
页码:113 / 120
页数:8
相关论文
共 16 条
[1]   LONG-TERM PLASMA-GLUCOSE NORMALIZATION IN EXPERIMENTAL DIABETIC RATS WITH MACROENCAPSULATED IMPLANTS OF BENIGN HUMAN INSULINOMAS [J].
ALTMAN, JJ ;
HOULBERT, D ;
CALLARD, P ;
MCMILLAN, P ;
SOLOMON, BA ;
ROSEN, J ;
GALLETTI, PM .
DIABETES, 1986, 35 (06) :625-633
[2]   MICROENCAPSULATED ISLET GRAFTS IN THE BB/E RAT - A POSSIBLE ROLE FOR CYTOKINES IN GRAFT FAILURE [J].
COLE, DR ;
WATERFALL, M ;
MCINTYRE, M ;
BAIRD, JD .
DIABETOLOGIA, 1992, 35 (03) :231-237
[3]  
HELMKE K, 1982, HORM METAB RES S, V12, P45
[4]  
IWATA H, 1992, TRANSPLANT P, V24, P1517
[5]   AGAROSE FOR A BIOARTIFICIAL PANCREAS [J].
IWATA, H ;
TAKAGI, T ;
AMEMIYA, H ;
SHIMIZU, H ;
YAMASHITA, K ;
KOBAYASHI, K ;
AKUTSU, T .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1992, 26 (07) :967-977
[6]   EFFECT OF TRANSPLANTATION SITE AND ALPHA-L3T4 TREATMENT ON SURVIVAL OF RAT, HAMSTER, AND RABBIT ISLET XENOGRAFTS IN MICE [J].
LACY, PE ;
RICORDI, C ;
FINKE, EH .
TRANSPLANTATION, 1989, 47 (05) :761-766
[7]   ISLET TRANSPLANTATION WITH IMMUNOISOLATION [J].
LANZA, RP ;
SULLIVAN, SJ ;
CHICK, WL .
DIABETES, 1992, 41 (12) :1503-1510
[8]   XENOGRAFTS OF RAT ISLETS INTO DIABETIC MICE - AN EVALUATION OF NEW SMALLER CAPSULES [J].
LUM, ZP ;
KRESTOW, M ;
TAI, IT ;
VACEK, I ;
SUN, AM .
TRANSPLANTATION, 1992, 53 (06) :1180-1183
[9]   PROLONGATION OF PANCREATIC-ISLET XENOGRAFT SURVIVAL AND THYMUS ALTERATION BY 15-DEOXYSPERGUALIN [J].
NAKAJIMA, Y ;
YABUUCHI, H ;
KANEHIRO, H .
TRANSPLANTATION, 1989, 48 (02) :351-352
[10]  
NORMURA M, 1981, IYOUDENNSHI TO SEITA, V19, P203